CalvinC.ShengMD
Cardiology • Indianapolis, INInterventional Cardiology, Peripheral Endovascular Interventional Cardiology
Coronary and structural interventionist at Franciscan Health
Dr. Sheng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5330 E Stop 11 Rd
Indianapolis, IN 46237Phone+1 317-893-1900Fax+1 317-893-1901
Summary
- Dr. Calvin Sheng is a cardiologist in Cleveland, OH and is affiliated with Cleveland Clinic. He received his medical degree from Vanderbilt University School of Medicine and has been in practice 6 years. He also speaks multiple languages, including Chinese (Mandarin). He specializes in interventional cardiology, structural cardiology, CHIP, and peripheral endovascular interventions. He has more than 10 publications and over 500 citings.
Education & Training
Cleveland Clinic FoundationFellowship, Interventional Cardiology, 2022 - 2024- Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 2019 - 2022
Johns Hopkins UniversityResidency, Internal Medicine, 2016 - 2019
Vanderbilt University School of MedicineClass of 2016, MD, AOA
Duke UniversityBS, Biology, Magna Cum Laude, PKB, 2007 - 2011
Certifications & Licensure
OH State Medical License 2019 - 2026
IN State Medical License 2024 - 2025
MD State Medical License 2016 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
- Certification Board of Nuclear Cardiology (CBNC)American Society of Nuclear Cardiology (ASNC)
- National Board of Echocardiography (NBE)American Society of Echocardiography (ASE)
- Registered Physician in Vascular Interpretations (RPVI)The Alliance for Physician Certification & Advancement (APCA)
Awards, Honors, & Recognition
- Alpha Omega Alpha 2016
- Sarnoff Cardiovascular Research Fellowship 2014-2015
- Phi Kappa Beta 2011
- Join now to see all
Clinical Trials
- Canakinumab in Covid-19 Cardiac Injury (The Three C Study) Start of enrollment: 2020 Apr 24
- Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation Start of enrollment: 2020 May 20
Publications & Presentations
PubMed
- 415 citationsTitin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathyJohn T. Hinson, Anant Chopra, N. Nafissi, William J. Polacheck, Craig C. Benson
Science. 2015-08-28 - 16 citationsSARS-CoV-2 Myocarditis: Insights Into Incidence, Prognosis, and Therapeutic Implications.Ossama K. Abou Hassan, Calvin C Sheng, Tom Kai Ming Wang, Paul Cremer
Current Cardiology Reports. 2021-08-03 - 95 citationsForce Generation via β-Cardiac Myosin, Titin, and α-Actinin Drives Cardiac Sarcomere Assembly from Cell-Matrix AdhesionsAnant Chopra, Matthew L. Kutys, Kehan Zhang, William J. Polacheck, Calvin C. Sheng
Developmental Cell. 2018-01-08
Journal Articles
- 21st Century Cardio-Oncology: Identifying Cardiac Safety Signals in the Era of Personalized MedicineSheng, C.C., L. Amiri-Kordestani, T. Palmby, T. Force, C.C. Hong, J. C. Wu, G. Kim, & J. Moslehi, JACC-BTS
Other Languages
- Chinese (Mandarin)
External Links
- LinkedInhttps://www.linkedin.com/in/calvin-sheng-78622568/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
